Adaptive Biotechnologies Corporation (ADPT)
NASDAQ·Healthcare·Biotechnology
$27.65
—
Mkt Cap $4.07B
Analyst Ratings
Buy
13
Hold
4
Sell
0
Price Target (20 analysts)
$30.42
Range $20.00 – $35.00
Implied Upside
+10.0%
Consensus $30.42 vs current $27.65
NASDAQ·Healthcare·Biotechnology
$27.65
—
Mkt Cap $4.07B
Buy
13
Hold
4
Sell
0
Price Target (20 analysts)
$30.42
Range $20.00 – $35.00
+10.0%
Consensus $30.42 vs current $27.65